• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VASCUTEK LTD GELWEAVE; GELWEAVE BIFURCATE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VASCUTEK LTD GELWEAVE; GELWEAVE BIFURCATE Back to Search Results
Model Number GELWEAVE BIFURCATE
Device Problem Material Integrity Problem (2978)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/29/2021
Event Type  malfunction  
Manufacturer Narrative
The site advised that the device is not available as it was discarded; therefore no evaluation of the graft was possible.(b)(4).Type of investigation - review of similar complaints of leakage for all gelweave branded devices gave an occurrence rate of (b)(4).Type of investigation - information has been requested on multiple occasions from the clinician regarding the procedure and how the graft was used.If additional information is supplied by the reporting site; a follow up report will be generated documenting any updates in the investigation.Type of investigation - a review of the retained qc and manufacturing records for this batch (with attention to all in process and base material porosity testing) confirmed that the batch was manufactured to its design specification.Type of investigation - the site advised that the device is not available.Investigation findings - no issue was found with the manufacturing of the batch (based on the review of the retained production records).Investigation conclusions - the root cause of the reported defect could not be determined.Vascutek ltd.Considers this event as closed.Further action is not planned, however, the issue will be tracked and trended as part of the on-going complaints trending and reporting process, if an adverse trend develops action may be taken at that time.
 
Event Description
On (b)(6) 2021 a gelweave bifurcate graft appeared to leak during a leak test (completed on site at the hospital) allegedly after being implanted and then extracted from the body.The event was reported as device related.Device is not available as it was discarded.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GELWEAVE
Type of Device
GELWEAVE BIFURCATE
Manufacturer (Section D)
VASCUTEK LTD
newmains avenue
inchinnan business park
renfrewshire, PA4 9 RR
UK  PA4 9RR
Manufacturer (Section G)
VASCUTEK LTD
newmains avenue
inchinnan business park
renfrewshire, PA4 9 RR
UK   PA4 9RR
Manufacturer Contact
jason whittle
newmains avenue
inchinnan business park
renfrewshire, PA4 9-RR
UK   PA4 9RR
MDR Report Key11884304
MDR Text Key254821422
Report Number9612515-2021-00016
Device Sequence Number1
Product Code DSY
UDI-Device Identifier05037881105819
UDI-Public05037881105819
Combination Product (y/n)N
Reporter Country CodeRP
PMA/PMN Number
K964665
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 05/26/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/26/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2023
Device Model NumberGELWEAVE BIFURCATE
Device Catalogue Number731608-G
Device Lot Number21540851
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/03/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-